Potato “Vaccine” Developer – Ascribe Bioscience – Receives Strategic Investment
Source Agriculture Corp, an innovative agri-tech investment firm, recently made a strategic investment in Ascribe Bioscience, a cutting-edge startup focused on developing sustainable crop protection solutions.
Ascribe was established in 2017 to help farmers adopt more dependable, economical, and ecologically friendly farming methods by finding natural products derived from the soil microbiome.
By preparing plants’ natural defensive mechanisms against infections, Ascribe Bioscience’s flagship product, Phytalix, functions similarly to vaccination for plants. Phytalix, which is based on naturally occurring chemicals made by soil organisms, has demonstrated effectiveness in managing a wide range of diseases in a variety of crops, such as potatoes. The product is an eco-friendly substitute for costly biological treatments and chemical pesticides because it is non-toxic, biodegradable, and non-GMO.
By stimulating the plant’s immune system, Phytalix enables crops to react to stressors like infections more quickly. When used as a foliar spray or seed treatment, the product uses a small amount of active ingredient per acre, which lowers crop protection costs and increases the sustainability of farming methods.
Through sophisticated metabolomics, Ascribe’s patented technology discovers tiny chemicals that improve plant production and health, thereby unlocking the potential of the soil microbiome. As a result of this discovery, biobased products that are more dependable in a variety of field settings and shelf-stable than conventional live microorganisms or complex combinations have been developed.
“We believe that Ascribe Bioscience’s approach represents the future of sustainable crop protection. Their innovative platform and commitment to natural, effective solutions align perfectly with Source Agriculture’s mission to support technologies that not only improve farming productivity but also contribute to environmental sustainability. Our investment in Ascribe is a testament to our confidence in their ability to deliver impactful, science-driven solutions for farmers around the world,” Aman Gill, President and CEO of Source Agriculture Corp, mentioned.
With this calculated investment, Source Agriculture Corp. keeps expanding its portfolio of businesses devoted to developing high-tech, sustainable agricultural solutions. The Ascribe Bioscience activity has the potential to significantly modify the way the global agriculture sector handles crop protection and environmental stewardship by providing a valuable substitute for costly biological products and hazardous pesticides.
